Zimbabwe is preparing to roll out a groundbreaking HIV prevention tool, making it one of the first countries in the world to adopt Lenacapavir, a long-acting injectable medication. More than 46,000 people identified as being at high risk of infection will begin receiving the injection on Wednesday, 18 February, with the official launch scheduled in Epworth, Harare.